tiprankstipranks
Trending News
More News >
Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ:CVKD
US Market

Cadrenal Therapeutics, Inc. (CVKD) Financial Statements

Compare
417 Followers

Cadrenal Therapeutics, Inc. Financial Overview

Cadrenal Therapeutics, Inc.'s market cap is currently $18.40M. The company's EPS TTM is $-1.31; its P/E ratio is -0.98; Cadrenal Therapeutics, Inc. is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-1.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.88K$ 0.00$ -1.27K
Operating Income$ -10.96M$ -7.63M$ -2.70M
EBITDA$ -10.65M$ -8.34M$ -6.61M
Net Income$ -10.65M$ -8.36M$ -6.71M
Balance Sheet
Cash & Short-Term Investments$ 10.02M$ 8.40M$ 32.59K
Total Assets$ 10.12M$ 8.52M$ 778.17K
Total Debt$ 0.00$ 21.35K$ 640.71K
Net Debt$ -10.02M$ -8.38M$ 608.12K
Total Liabilities$ 2.68M$ 826.88K$ 6.33M
Stockholders' Equity$ 7.44M$ 7.69M$ -5.55M
Cash Flow
Free Cash Flow$ -7.36M$ -3.53M$ -1.20M
Operating Cash Flow$ -7.36M$ -3.53M$ -1.20M
Investing Cash Flow$ -6.54K$ -3.25K$ -2.28K
Financing Cash Flow$ 8.98M$ 11.90M$ 1.24M
Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History

Cadrenal Therapeutics, Inc. Debt to Assets

Cadrenal Therapeutics, Inc. Cash Flow

Cadrenal Therapeutics, Inc. Forecast EPS vs Actual EPS